Ibrutinib does not reverse disease- and treatment-related hypogammaglobulinaemia associated with chronic lymphocytic leukemia
(2021)
Journal Article
Khan, S., Durairaj, S., Phumphukhieo, P., Holding, S., & Allsup, D. (2021). Ibrutinib does not reverse disease- and treatment-related hypogammaglobulinaemia associated with chronic lymphocytic leukemia. Leukemia & Lymphoma, 1-8. https://doi.org/10.1080/10428194.2021.1885662
All Outputs (12)
Textural analysis demonstrates heterogeneous [18F]-fluorodeoxyglucose uptake in radiologically normal lung in patients with idiopathic pulmonary fibrosis (2018)
Journal Article
Aliyu, S. A., Avery, G., Cawthorne, C., Archibald, S. J., Kadir, T., Willaime, J. M., …Crooks, M. G. (2018). Textural analysis demonstrates heterogeneous [18F]-fluorodeoxyglucose uptake in radiologically normal lung in patients with idiopathic pulmonary fibrosis. European respiratory journal, 52(5), 1801138. https://doi.org/10.1183/13993003.01138-2018Positron Emission Tomography (PET) scanning in idiopathic pulmonary fibrosis (IPF) has revealed increased [18F]-fluorodeoxyglucose ([18F]-FDG) uptake in areas of the lungs that appear normal on high resolution computed tomography (HRCT). We hypothesi... Read More about Textural analysis demonstrates heterogeneous [18F]-fluorodeoxyglucose uptake in radiologically normal lung in patients with idiopathic pulmonary fibrosis.
Evaluating STZ-Induced Impaired Wound Healing in Rats (2017)
Journal Article
Ansell, D. M., Marsh, C., Walker, L., Hardman, M. J., & Holden, K. (2018). Evaluating STZ-Induced Impaired Wound Healing in Rats. Journal of Investigative Dermatology, 138(4), 994-997. https://doi.org/10.1016/j.jid.2017.10.020
Reply regarding prognostic value of neutrophil-to-lymphocyte ratio in laryngeal squamous cell carcinoma (2017)
Journal Article
Wong, B. Y., Stafford, N. D., Green, V. L., & Greenman, J. (2017). Reply regarding prognostic value of neutrophil-to-lymphocyte ratio in laryngeal squamous cell carcinoma. Head & neck, 39(3), 615. https://doi.org/10.1002/hed.24660
In silico analysis highlights the copy number variation mechanism responsible for the historically reported VWF exon 42 deletion (2016)
Journal Article
Cartwright, A., Peake, I. R., Goodeve, A. C., & Hampshire, D. J. (2016). In silico analysis highlights the copy number variation mechanism responsible for the historically reported VWF exon 42 deletion. Haemophilia, 22(5), e484-e487. https://doi.org/10.1111/hae.13059Letter to the editor
Common variation at 12q24.13 (OAS3) influences chronic lymphocytic leukemia risk (2014)
Journal Article
Sava, G. P., Speedy, H. E., Di Bernardo, M. C., Dyer, M. J., Holroyd, A., Sunter, N. J., …Houlston, R. S. (2015). Common variation at 12q24.13 (OAS3) influences chronic lymphocytic leukemia risk. Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K, 29(3), 748-751. https://doi.org/10.1038/leu.2014.311
P.P2063S: A neutral VWF variant masquerading as a mutation (2013)
Journal Article
Hampshire, D. J., & Goodeve, A. C. (2014). P.P2063S: A neutral VWF variant masquerading as a mutation. Annals of Hematology, 93(3), 505-506. https://doi.org/10.1007/s00277-013-1817-yLetter to the Editor
High and low, but not intermediate, PRAME expression levels are poor prognostic markers in myelodysplastic syndrome at disease presentation (2013)
Journal Article
Liberante, F. G., Pellagatti, A., Boncheva, V., Bowen, D. T., Mills, K. I., Boultwood, J., & Guinn, B. A. (2013). High and low, but not intermediate, PRAME expression levels are poor prognostic markers in myelodysplastic syndrome at disease presentation. British journal of haematology, 162(2), 282-285. https://doi.org/10.1111/bjh.12352
Authors' reply: Expanding horizons in metastatic prostate cancer treatment (2011)
Journal Article
Sturge, J., Caley, M. P., & Waxman, J. (2011). Authors' reply: Expanding horizons in metastatic prostate cancer treatment. Nature Reviews Clinical Oncology, 8(10), 625. https://doi.org/10.1038/nrclinonc.2011.67-c2
Expression of CD66 in non-Hodgkin lymphomas and multiple myeloma (2011)
Journal Article
Guinn, B. A., Bosslet, K., Lee, C., Richardson, D., & Orchard, K. (2011). Expression of CD66 in non-Hodgkin lymphomas and multiple myeloma. European Journal of Haematology, 87(6), 554-555. https://doi.org/10.1111/j.1600-0609.2011.01698.x
G-protein coupled and ITAM receptor regulation of the formin FHOD1 through Rho Kinase in platelets (2011)
Journal Article
Thomas, S. G., Calaminus, S., Machesky, L. M., Alberts, A. S., & Watson, S. P. (2011). G-protein coupled and ITAM receptor regulation of the formin FHOD1 through Rho Kinase in platelets. Journal of thrombosis and haemostasis : JTH, 9(8), 1648-1651. https://doi.org/10.1111/j.1538-7836.2011.04357.x
Effect of the VWF promoter (GT) n repeat and single-nucleotide polymorphism c.-2527G>A on circulating von Willebrand factor levels under normal conditions (2011)
Journal Article
Hickson, N., Hampshire, D., Castaman, G., Eikenboom, J., Rodeghiero, F., Peake, I., & Goodeve, A. (2011). Effect of the VWF promoter (GT) n repeat and single-nucleotide polymorphism c.-2527G>A on circulating von Willebrand factor levels under normal conditions. Journal of thrombosis and haemostasis : JTH, 9(3), 603-605. https://doi.org/10.1111/j.1538-7836.2010.04161.x